Price no longer tells the story when the market becomes more discriminating. Investors begin searching what can continue to ...

The iShares Core Dividend Growth ETF (NYSEARCA:DGRO) delivers exactly what its name promises: dividend growth, not dividend ...

Growth stocks have consistently outperformed most other asset classes in recent years, cementing their place as essential components of well-balanced portfolios. Their potential for high rewards, ...

Chagee (CHA) remains a hold as overseas growth is too small to offset domestic weakness and negative same-store sales trends.

When large holders shift their attention, the market usually notices later. Whales tend to rotate before the crowd, n ...

Discover how return on retained earnings (RORE) measures reinvested profits and indicates a company's growth potential. Learn its impact on business efficiency.

Officials are planning for potential growth around Interstate 15 between Sloan and the California state line and what travel effects that might have on the important stretch of highway. The area that ...

Jazz Pharmaceuticals' diversified drug portfolio drives revenue growth, but mixed clinical results and a 30% 10-year share price decline raise concerns. Zanidatamab, targeting HER2-positive cancers, ...

Intuitive Machines secured a NASA contract worth up to $4.82 billion, positioning it as a leader in the emerging trillion-dollar space industry. Summit Therapeutics' ivonescimab outperformed the world ...